William C. Cushman

65.1k total citations · 15 hit papers
265 papers, 39.3k citations indexed

About

William C. Cushman is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, William C. Cushman has authored 265 papers receiving a total of 39.3k indexed citations (citations by other indexed papers that have themselves been cited), including 184 papers in Cardiology and Cardiovascular Medicine, 90 papers in Endocrinology, Diabetes and Metabolism and 39 papers in Economics and Econometrics. Recurrent topics in William C. Cushman's work include Blood Pressure and Hypertension Studies (165 papers), Hormonal Regulation and Hypertension (57 papers) and Heart Rate Variability and Autonomic Control (37 papers). William C. Cushman is often cited by papers focused on Blood Pressure and Hypertension Studies (165 papers), Hormonal Regulation and Hypertension (57 papers) and Heart Rate Variability and Autonomic Control (37 papers). William C. Cushman collaborates with scholars based in United States, United Kingdom and Canada. William C. Cushman's co-authors include Jackson T. Wright, George L. Bakris, Barry J. Materson, Henry R. Black, Joseph L. Izzo, Aram V. Chobanian, Suzanne Oparil, Edward J. Roccella, Daniel W. Jones and Lee A. Green and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

William C. Cushman

255 papers receiving 37.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

2003 10.3k citations George L. Bakris, William C. Cushman et al. Hypertension profile →
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults

2013 5.7k citations Suzanne Oparil, William C. Cushman et al. profile →
Effects of Intensive Glucose Lowering in Type 2 Diabetes

2008 5.5k citations William C. Cushman et al. profile →
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

2013 1.9k citations William B. White, Christopher P. Cannon et al. profile →
Resistant Hypertension: Diagnosis, Evaluation, and Treatment

2008 1.7k citations William C. Cushman, William B. White et al. Circulation profile →
THE SEVENTH REPORT OF THE JOINT NATIONAL COMMITTEE ON PREVENTION, DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD PRESSURE. THE JNC 7 REPORT

2003 1.2k citations George L. Bakris, William C. Cushman et al. profile →
Resistant Hypertension: Diagnosis, Evaluation, and Treatment

2008 1.0k citations William C. Cushman, William B. White et al. Hypertension profile →
Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo

1993 900 citations William C. Cushman et al. profile →
Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

2002 742 citations William C. Cushman, Jeffrey A. Cutler et al. profile →
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

2021 657 citations Alfred K. Cheung, Tara I. Chang et al. profile →
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

2015 551 citations Faı̈ez Zannad, Christopher P. Cannon et al. profile →
Diabetes and hypertension: the bad companions

2012 472 citations William C. Cushman et al. profile →
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)

2014 360 citations Walter T. Ambrosius, Alfred K. Cheung et al. profile →
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

2021 176 citations Alfred K. Cheung, Tara I. Chang et al. profile →
Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension

2021 131 citations William C. Cushman et al. Hypertension profile →

Peers

Countries citing papers authored by William C. Cushman

Since Specialization

Citations

This map shows the geographic impact of William C. Cushman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Cushman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Cushman more than expected).

Fields of papers citing papers by William C. Cushman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William C. Cushman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Cushman. The network helps show where William C. Cushman may publish in the future.

Co-authorship network of co-authors of William C. Cushman

This figure shows the co-authorship network connecting the top 25 collaborators of William C. Cushman. A scholar is included among the top collaborators of William C. Cushman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Cushman. William C. Cushman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of intensive blood pressure treatment on orthostatic hypertension: individual level meta-analysis 2025 ·BMJ ·Stephen P. Juraschek, Jiun‐Ruey Hu, (unknown), Carol Mita, Lewis A. Lipsitz, Lawrence J. Appel, Nigel Beckett, (unknown), Rury R. Holman, Edgar R. Miller, Kenneth J. Mukamal, (unknown), Jan A. Staessen, Addison A. Taylor, Jackson T. Wright, William C. Cushman	2
2	Trends in Initial Antihypertensive Medication Prescribing Among >2.8 Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019 2024 ·Journal of the American Heart Association ·Yizhe Xu, Catherine G. Derington, (unknown), (unknown), Joshua A. Jacobs, April F. Mohanty, Jaejin An, William C. Cushman, P. Michael Ho, Brandon K. Bellows, Jordana B. Cohen, Adam P. Bress	3
3	Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial 2024 ·Clinical Journal of the American Society of Nephrology ·Shweta Bansal, Robert E. Boucher, Jincheng Shen, Guo Wei, Glenn M. Chertow, Paul K. Whelton, William C. Cushman, Alfred K. Cheung, Srinivasan Beddhu, (unknown)	0
4	The impact of COVID-19 on a large pragmatic clinical trial embedded in primary care 2023 ·Contemporary Clinical Trials ·Sarah Leatherman, Cynthia Hau, (unknown), Peter Glassman, Addison A. Taylor, Ryan Ferguson, William C. Cushman, Areef Ishani	2
5	Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial 2023 ·Hypertension ·Jordan B. King, Catherine G. Derington, Jennifer S. Herrick, Joshua A. Jacobs, Alexander R. Zheutlin, Molly B. Conroy, William C. Cushman, Adam P. Bress	5
6	Racial and ethnic disparities in the enrolment of medicare medication therapy management programs 2023 ·Journal of Pharmaceutical Health Services Research ·(unknown), (unknown), Jim Y. Wan, Ya‐Chen Tina Shih, Marie A. Chisholm‐Burns, Samuel Dagogo‐Jack, William C. Cushman, (unknown), (unknown), (unknown), Junling Wang	1
7	Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed‐Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020 2023 ·Journal of the American Heart Association ·Catherine G. Derington, Adam P. Bress, Jennifer S. Herrick, Joshua A. Jacobs, Alexander R. Zheutlin, (unknown), Molly B. Conroy, William C. Cushman, Jordan B. King	14
8	Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis 2023 ·Hypertension ·Zeinab Bidel, Milad Nazarzadeh, Dexter Canoy, Emma Copland, Eva Gerdts, Mark Woodward, Ajay Gupta, Christopher M. Reid, William C. Cushman, Kristian Wachtell, Koon Teo, Barry R. Davis, John Chalmers, Carl J. Pepine, Kazem Rahimi	11
9	Late-Breaking Science Abstracts and Featured Science Abstracts From the American Heart Association's Scientific Sessions 2022 and Late-Breaking Abstracts in Resuscitation Science From the Resuscitation Science Symposium 2022 2022 ·Circulation ·Robert J. Mentz, (unknown), Eric L. Eisenstein, (unknown), Stephen J. Greene, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eric J. Velazquez, (unknown), William C. Cushman, (unknown)	9
10	Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial 2022 ·Hypertension ·Catherine G. Derington, Adam P. Bress, Andrew E. Moran, William S. Weintraub, Jennifer S. Herrick, William C. Cushman, Ian M. Kronish, Barry M. Stults, Daichi Shimbo, Paul Muntner, Tom Greene, Jeffrey T. Bates, Tara I. Chang, Lois Katz, Shakaib U. Rehman, Christianne L. Roumie, Leonardo Tamariz, Jordan B. King	6
11	Blood Pressure Intervention and Control in SPRINT 2022 ·Hypertension ·William C. Cushman, Robert Ringer, Carlos J. Rodríguez, Gregory W. Evans, Jeffrey T. Bates, Jeffrey A. Cutler, Amret Hawfield, Dalane W. Kitzman, Ilya M. Nasrallah, Suzanne Oparil, John Nord, Vasilios Papademetriou, Karen S. Servilla, Peter Van Buren, Paul K. Whelton, Jeff Whittle, Jackson T. Wright	15
12	Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline 2021 ·Annals of Internal Medicine ·Charles Tomson, Alfred K. Cheung, Johannes F.E. Mann, Tara I. Chang, William C. Cushman, Susan L. Furth, Fan Fan Hou, Greg Knoll, Paul Muntner, Roberto Pecoits‐Filho, Sheldon W. Tobe, Lyubov Lytvyn, Jonathan C. Craig, David J. Tunnicliffe, Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Joachim H. Ix, Mark J. Sarnak	36
13	SPRINT Revisited: Updated Results and Implications 2021 ·Hypertension ·Jackson T. Wright, Paul K. Whelton, Karen Johnson, Joni K. Snyder, David M. Reboussin, William C. Cushman, Jeff D. Williamson, Nicholas M. Pajewski, Alfred K. Cheung, Cora E. Lewis, Suzanne Oparil, Michael V. Rocco, Srinivasan Beddhu, Lawrence J. Fine, Jeffrey A. Cutler, Walter T. Ambrosius, Mahboob Rahman, Carolyn H. Still, Zhengyi Chen, Curtis Tatsuoka	16
14	Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension 2020 ·Annals of Internal Medicine ·Stephen P. Juraschek, Jiun‐Ruey Hu, (unknown), Anthony Ishak, Carol Mita, Lewis A. Lipsitz, Lawrence J. Appel, Nigel Beckett, Ruth L. Coleman, William C. Cushman, Barry R. Davis, Greg Grandits, Rury R. Holman, Edgar R. Miller, Ruth Peters, Jan A. Staessen, Addison A. Taylor, Lutgarde Thijs, Jackson T. Wright, Kenneth J. Mukamal	49
15	Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT 2018 ·Journal of the American Heart Association ·Srinivasan Beddhu, Glenn M. Chertow, Tom Greene, Paul K. Whelton, Walter T. Ambrosius, Alfred K. Cheung, Jeffrey A. Cutler, Lawrence J. Fine, Robert E. Boucher, Guo Wei, Chong Zhang, Holly Kramer, Adam P. Bress, Paul L. Kimmel, Suzanne Oparil, Cora E. Lewis, Mahboob Rahman, William C. Cushman	70
16	Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension 2018 ·The American Journal of Cardiology ·Keith C. Ferdinand, George L. Bakris, William C. Cushman, Michael A. Weber, Eric Lloyd, Jingtao Wu, William B. White	4
17	Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension 2017 ·Circulation ·Elsayed Z. Soliman, Walter T. Ambrosius, William C. Cushman, Zhu-Ming Zhang, Jeffrey T. Bates, Javier A. Neyra, (unknown), Leonardo Tamariz, Lama Ghazi, Monique E. Cho, Brian P. Shapiro, Jiang He, Lawrence J. Fine, Cora E. Lewis	101
18	High‐sensitivity C ‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE ( Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care ) trial 2017 ·Diabetes Obesity and Metabolism ·You‐Cheol Hwang, David A. Morrow, Christopher P. Cannon, Yuyin Liu, Richard M. Bergenstal, Simon Heller, Cyrus R. Mehta, William C. Cushman, George L. Bakris, Faı̈ez Zannad, William B. White	30
19	Impact of Non-Adherence on Renal and Cardiovascular Outcomes in US Veterans 2015 ·American Journal of Nephrology ·Elvira O. Gosmanova, Miklos Z. Molnar, (unknown), Jun Lü, Elani Streja, William C. Cushman, Kamyar Kalantar‐Zadeh, Csaba P. Kövesdy	16
20	International Roundtable Discussion of National Guidelines for the Detection, Evaluation, and Treatment of Hypertension 1993 ·American Journal of Hypertension ·Michael H. Alderman, William C. Cushman, (unknown), (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact